Multiple endocrine neoplasia type 2A
MONDO:0008234An autosomal dominant tumor predisposition disorder caused by pathogenic variants in the RET gene, characterized by an increased risk of medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.
Also known as: MEA type 2a, MEA type II, MEN2A, RET-related multiple endocrine neoplasia type 2A, Sipple syndrome, men 2A, men type 2a, men type II
2775 clinical trials for this condition and its sub-types, 4 tagged with Multiple endocrine neoplasia type 2A itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New lung cancer vaccine trial launches for advanced patients
Disease control Recruiting nowThis early-stage trial is testing a new cancer vaccine called BNT116, alone or with other drugs, in people with advanced non-small cell lung cancer. The main goal is to find a safe dose and check for side effects. About 320 participants will be enrolled across several groups, inc…
Phase 1 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Hunt for hidden cancer genes: families needed to unlock hereditary secrets
Knowledge-focused Recruiting nowThis study aims to discover new genes that may cause certain cancers to run in families. Researchers will collect blood samples and health information from 1,500 people in families where multiple members have had cancer, especially childhood cancers. The goal is to build a regist…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC